Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lithium carbonate and bone mass in osteoporosis patients with mental illness
ChiCTR2500111219Phase 4Recruiting
- Sponsor
- Wuhan Mental Health Center
- Start
- Oct 2025
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of lithium carbonate in involutional osteoporosis (2 arms), sponsored by Wuhan Mental Health Center. Primary endpoints: Bone mineral density and Bone turnover markers. Started Oct 2025; status: recruiting.
02
Drugs
lithium carbonate
03
Conditions
involutional osteoporosis
Beyond the preview
Go deeper on ChiCTR2500111219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500111219.